Stocks: Mazor Robotics Ltd – (MZOR) Lowered to “Market Perform” at Wells Fargo & Co

Stocks: Mazor Robotics Ltd – (MZOR) Lowered to “Market Perform” at Wells Fargo & Co

Wells Fargo & Co downgraded shares of Mazor Robotics Ltd – (NASDAQ:MZOR) from an outperform rating to a market perform rating in a research report sent to investors on Thursday morning.

A number of other analysts have also recently commented on the company. First Analysis cut Mazor Robotics Ltd – from an overweight rating to an equal weight rating and upped their price objective for the company from $28.00 to $38.00 in a research report on Thursday. B. Riley reiterated a neutral rating and set a $31.00 price objective on shares of Mazor Robotics Ltd – in a research report on Wednesday. Barclays PLC cut Mazor Robotics Ltd – from an overweight rating to an equal weight rating and upped their price objective for the company from $31.00 to $32.00 in a research report on Monday, April 24th. They noted that the move was a valuation call. Zacks Investment Research upgraded Mazor Robotics Ltd – from a sell rating to a hold rating in a research report on Saturday, April 22nd. Finally, Standpoint Research cut Mazor Robotics Ltd – from a buy rating to a reduce rating and reduced their price objective for the company from $32.98 to $28.00 in a research report on Wednesday, April 19th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company’s stock. Mazor Robotics Ltd – has an average rating of Hold and a consensus price target of $31.50.

Shares of Mazor Robotics Ltd – (NASDAQ:MZOR) traded down 3.04% during midday trading on Thursday, hitting $41.41. The stock had a trading volume of 369,718 shares. The stock’s 50-day moving average is $32.30 and its 200-day moving average is $25.03. The stock’s market cap is $988.66 million. Mazor Robotics Ltd – has a 12 month low of $10.00 and a 12 month high of $44.00.

Mazor Robotics Ltd – (NASDAQ:MZOR) last posted its quarterly earnings data on Wednesday, May 10th. The medical instruments supplier reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by $0.02. The firm had revenue of $11.70 million for the quarter, compared to analysts’ expectations of $11.49 million. Mazor Robotics Ltd – had a negative net margin of 55.57% and a negative return on equity of 40.07%. The firm’s revenue was up 82.8% compared to the same quarter last year. During the same quarter last year, the company posted ($0.10) EPS. Equities analysts anticipate that Mazor Robotics Ltd – will post ($0.77) EPS for the current year.

A number of hedge funds have recently modified their holdings of the company. OppenheimerFunds Inc. boosted its stake in shares of Mazor Robotics Ltd – by 21.0% in the first quarter. OppenheimerFunds Inc. now owns 915,780 shares of the medical instruments supplier’s stock worth $27,263,000 after buying an additional 158,690 shares during the last quarter. Menora Mivtachim Holdings LTD. boosted its stake in shares of Mazor Robotics Ltd – by 57.2% in the first quarter. Menora Mivtachim Holdings LTD. now owns 235,867 shares of the medical instruments supplier’s stock worth $7,022,000 after buying an additional 85,867 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. boosted its stake in shares of Mazor Robotics Ltd – by 29.4% in the fourth quarter. Harel Insurance Investments & Financial Services Ltd. now owns 210,035 shares of the medical instruments supplier’s stock worth $5,245,000 after buying an additional 47,777 shares during the last quarter. Candriam Luxembourg S.C.A. boosted its stake in shares of Mazor Robotics Ltd – by 26.7% in the first quarter. Candriam Luxembourg S.C.A. now owns 186,167 shares of the medical instruments supplier’s stock worth $5,542,000 after buying an additional 39,232 shares during the last quarter. Finally, Credit Agricole S A bought a new stake in shares of Mazor Robotics Ltd – during the first quarter worth approximately $3,929,000. Institutional investors and hedge funds own 24.72% of the company’s stock.

About Mazor Robotics Ltd –

Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.

Related posts

Leave a Comment